Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for SiBone (SIBN : NSDQ)
 
 • Company Description   
SI-BONE Inc. is a medical device company which developed the iFuse Implant System(R) for minimally invasive surgical treatment of the sacroiliac joint dysfunction. SI-BONE Inc. is based in Santa Clara, California.

Number of Employees: 352

 
 • Price / Volume Information   
Yesterday's Closing Price: $13.89 Daily Weekly Monthly
20 Day Moving Average: 371,649 shares
Shares Outstanding: 33.88 (millions)
Market Capitalization: $470.64 (millions)
Beta: 1.40
52 Week High: $34.38
52 Week Low: $11.92
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -35.96% -30.11%
12 Week -27.32% -23.48%
Year To Date -37.46% -27.10%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
471 EL CAMINO REAL SUITE 101
-
SANTA CLARA,CA 95050
USA
ph: 408-207-0700
fax: -
investors@si-bone.com http://si-bone.com
 
 • General Corporate Information   
Officers
Laura A. Francis - Chief Executive Officer
Jeffrey W. Dunn - Executive Chairman
Anshul Maheshwari - Chief Financial Officer
John G. Freund - Director
Jeryl L. Hilleman - Director

Peer Information
SiBone (ABMD)
SiBone (DMDS)
SiBone (CPWY.)
SiBone (EQUR)
SiBone (ECIA)
SiBone (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 825704109
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/01/22
Share - Related Items
Shares Outstanding: 33.88
Most Recent Split Date: (:1)
Beta: 1.40
Market Capitalization: $470.64 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.50 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.84 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 8.87% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/01/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 3.84
Price/Cash Flow: -
Price / Sales: 5.11
EPS Growth
vs. Year Ago Period: -40.54%
vs. Previous Quarter: -20.93%
Sales Growth
vs. Year Ago Period: 9.77%
vs. Previous Quarter: -11.06%
ROE
03/31/22 - -44.52
12/31/21 - -38.10
09/30/21 - -32.49
ROA
03/31/22 - -32.13
12/31/21 - -28.02
09/30/21 - -24.32
Current Ratio
03/31/22 - 10.44
12/31/21 - 10.41
09/30/21 - 12.75
Quick Ratio
03/31/22 - 9.48
12/31/21 - 9.73
09/30/21 - 12.04
Operating Margin
03/31/22 - -67.00
12/31/21 - -62.75
09/30/21 - -58.66
Net Margin
03/31/22 - -67.00
12/31/21 - -62.75
09/30/21 - -58.66
Pre-Tax Margin
03/31/22 - -67.00
12/31/21 - -62.75
09/30/21 - -58.66
Book Value
03/31/22 - 3.61
12/31/21 - 4.01
09/30/21 - 4.32
Inventory Turnover
03/31/22 - 1.01
12/31/21 - 1.12
09/30/21 - 1.19
Debt-to-Equity
03/31/22 - 0.29
12/31/21 - 0.26
09/30/21 - 0.24
Debt-to-Capital
03/31/22 - 22.24
12/31/21 - 20.65
09/30/21 - 19.56
 

Powered by Zacks Investment Research ©